Articles in Drugs
No more gifts or freebies for Massachusetts doctors from pharmaceutical companies, that is what Senate President Therese Murray is proposing. The ban would make Massachusetts the first state in the country to ban such gifts …
A new study from the AARP group points to increased drug costs putting extra strain on the elderly in the United States. AARP released information that brand name drug prices went up by an average …
Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company have announced that a new drug for treatment of bipolar disorder in children and adolescents is now available. ABILIFY (aripiprazole) has been approved by the FDA for …
Baxter announced a voluntary recall of all remaining lots of various heparin related drugs and heparin flush products. The initial recall was announced January 17, 2008 as a precautionary measure as reports came in of …
The FDA approved esomeprazole (Nexium) to help short term gastroesophagel reflux disease (GERD) in children between the ages of 1 and 11. The drug was approved in 2 forms: the delayed release capsule and a …
New research appearing in the March edition of Diabetes Care shows an increase in mortality among women who are restricting their insulin use who have Type I diabetes.
China’s State Food and Drug Administration said in a recent released statement that it is the receiving country’s responsibility to ensure the safety of pharmaceutical ingredients they import from other countries.
Over half the teenagers who were recently observed in a study published in JAMA have shown considerable improvement overcoming depression. This is great news in the face of the fact that many teenagers don’t …
Reserachers from the Herbert Irving Comprehensive Cancer Center of New York Presbyterian Hospital and Columbia Medical Center have released promising findings of the drug Abraxane’s ability to offer alternatives to surgery for bladder cancer patients.
The February issue of JAMA released a report showing a positive correlation between a class of drugs called ertyhropoiesis-stimulating agents (ESAs) and blood clots that are deep in the leg veins – venous thromboembolism (VTE).
